The synthetic purine reversine selectively induces cell death of cancer cells

Reversine, a 2,6-disubstituted Purine, as an Anti-cancer Agent in Differentiated and Undifferentiated Thyroid Cancer Cells

(2012) Shih-Che Hua et al.   PHARMACEUTICAL RESEARCH

Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine

(2010) L Anastasia et al.   CELL DEATH AND DIFFERENTIATION

Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine

(2010) Stefano Santaguida et al.   JOURNAL OF CELL BIOLOGY

Beneficial Effects of Reversine on In Vitro Development of Miniature Pig Somatic Cell Nuclear Transfer Embryos

(2010) Kazuchika MIYOSHI et al.   JOURNAL OF REPRODUCTION AND DEVELOPMENT

Proteomic signature of reversine-treated murine fibroblasts by 2-D difference gel electrophoresis and MS: Possible associations with cell signalling networks

(2009) Chiara Fania et al.   ELECTROPHORESIS

The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts

(2008) G Amabile et al.   CELL DEATH AND DIFFERENTIATION

Reversine Increases the Plasticity of Lineage-committed Cells toward Neuroectodermal Lineage

(2008) Eun Kyung Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

(2008) A. M. D'Alise et al.   MOLECULAR CANCER THERAPEUTICS